11376362

Systems for Determining Insulin on Board and Recommending Insulin Therapy and Related Methods

PublishedJuly 5, 2022
Assigneenot available in USPTO data we have
InventorsBryan Mazlish
Technical Abstract

Patent Claims
18 claims

Legal claims defining the scope of protection, as filed with the USPTO.

1

1. A computer-implemented insulin delivery assistance system, comprising: a control unit: a non-transitory computer-readable storage medium storing instructions thereon that, when executed by the control unit, cause the computer-implemented insulin delivery assistance system to: receive blood glucose levels of a patient and insulin delivery information, wherein the insulin delivery information comprises information about automated or semi-automated insulin delivery to the patient over time; determine an estimated insulin-on-board (JOB) responsive to the insulin delivery information; and obtain a relative IOB that represents a difference between a reference IOB and the estimated JOB, the reference IOB representing an amount of insulin required to maintain blood glucose stasis of the patient; and a bolus calculator configured to determine a suggested bolus dose of insulin for a correction bolus or for a meal bolus, wherein the bolus calculator is configured to determine the suggested bolus dose of insulin by performing operations comprising: determining that a change to basal insulin delivery to the patient might affect future blood glucose levels based, at least in part, on the relative JOB; and determining if the suggested bolus dose of insulin is necessary based on modeling data.

2

2. The system of claim 1 , wherein the bolus calculator is configured to provide the suggested bolus dose of insulin to the patient responsive to determining that the suggested bolus dose of insulin is necessary.

3

3. The system of claim 1 , wherein the bolus calculator is configured to discard the suggested bolus dose of insulin responsive to determining that the suggested bolus dose of insulin is not necessary.

4

4. The system of claim 1 , wherein the bolus calculator is configured to: obtain a first set of projected blood glucose levels based, at least in part, on an anticipated meal intake; and obtain a second set of projected blood glucose levels responsive to the determining that the change to basal insulin delivery might affect future blood glucose levels.

5

5. The system of claim 4 , wherein the bolus calculator is configured to determine a meal bolus dose based, at least in part, on a difference between the second set of projected blood glucose levels and a target blood glucose level.

6

6. The system of claim 1 , wherein the bolus calculator is configured to determine a correction dose of insulin responsive to determining that a received blood glucose level is outside a target range for blood glucose levels.

7

7. The system of claim 1 , wherein the change to basal insulin delivery is an increase to basal insulin delivery or a decrease to basal insulin delivery.

8

8. The system of claim 1 , wherein the bolus calculator is configured to determine that the suggested bolus dose of insulin is necessary to keep blood glucose levels of a patient within a target range for blood glucose levels responsive to determining that delivery of the suggested bolus dose of insulin will compensate for received blood glucose levels outside the target range for blood glucose levels to be within the target range for blood glucose levels.

9

9. The system of claim 1 , wherein the bolus calculator is configured to determine that the suggested bolus dose of insulin is necessary to keep blood glucose levels of a patient within a target range for blood glucose levels responsive to determining that delivery of the suggested bolus dose of insulin will compensate for projected increased blood glucose levels due to anticipated meal intake to be within the target range for blood glucose levels.

10

10. A computer-implemented method for assisting with insulin delivery, comprising: receiving sensor blood glucose data of a patient and insulin delivery data, wherein the insulin delivery data comprises data corresponding to automated or semi-automated insulin delivery to the patient over time; determining an estimated insulin-on-board (JOB) responsive to the insulin delivery data and the sensor blood glucose data; obtaining a relative IOB responsive to a difference between a reference IOB and the estimated JOB, the reference IOB representing an amount of insulin required to maintain blood glucose stasis of the patient; determining a suggested bolus dose of insulin for a correction bolus or for a meal bolus; determining that a change to basal insulin delivery to the patient might affect future blood glucose levels based, at least in part, on the relative JOB; and determining if the bolus dose of insulin is necessary.

11

11. The method of claim 10 , further comprising providing the suggested bolus dose of insulin to the patient responsive to determining that the suggested bolus dose of insulin is necessary.

12

12. The method of claim 10 , further comprising discarding the suggested bolus dose of insulin responsive to determining that the suggested bolus dose of insulin is not necessary.

13

13. The method of claim 10 , further comprising: obtaining a first projected blood glucose levels based, at least in part, on an anticipated meal intake; and obtaining a second projected blood glucose levels responsive to the determining that the change to basal insulin delivery might affect future blood glucose levels.

14

14. The method of claim 13 , further comprising determining a meal bolus dose based, at least in part, on a difference between the second projected blood glucose level and a target blood glucose level.

15

15. The method of claim 10 , further comprising determining a correction dose of insulin responsive to detecting that an estimated blood glucose level is outside a target range for blood glucose levels.

16

16. The method of claim 10 , wherein the determining that a change to basal insulin delivery might affect future blood glucose levels comprises: detecting an increase to basal insulin delivery responsive to the relative JOB; or detecting a decrease to basal insulin delivery responsive to the relative JOB.

17

17. The method of claim 10 , wherein the determining whether the suggested bolus dose of insulin is necessary comprises determining that the suggested bolus dose of insulin is necessary to keep blood glucose levels of a patient within a target range for blood glucose levels responsive to determining that delivery of the suggested bolus dose of insulin will compensate for received blood glucose levels outside the target range for blood glucose levels to be within the target range for blood glucose levels.

18

18. The method of claim 10 , wherein the determining whether the suggested bolus dose of insulin is necessary comprises determining that the suggested bolus dose of insulin is necessary to keep blood glucose levels of a patient within a target range for blood glucose levels responsive to determining that delivery of the suggested bolus dose of insulin will compensate for projected increased blood glucose levels due to anticipated meal intake to be within the target range for blood glucose levels.

Patent Metadata

Filing Date

Unknown

Publication Date

July 5, 2022

Inventors

Bryan Mazlish

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “SYSTEMS FOR DETERMINING INSULIN ON BOARD AND RECOMMENDING INSULIN THERAPY AND RELATED METHODS” (11376362). https://patentable.app/patents/11376362

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.